
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Traitement
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Le traitement n’est pas supposé faire régresser ou disparaître les lésions rénales responsables de l’IRC qui sont généralement irréversibles. Cepen- dant, lorsque l’IRC progresse à cause d’une maladie évolutive (pyélonéphrite, obstruction urinaire chronique, lithiase rénale, lymphome rénal et certaines maladies à médiation immunitaire), le diagnostic et un traitement approprié de ces troubles peuvent permettre d’arrêter ou de ralentir la progression de la maladie rénale.
L’IRC est une maladie progressive et dynamique; par conséquent, des exa- mens cliniques et biologiques répétés sont essentiels pour l’efficacité du trai- tement. Celui-ci doit être modifié selon l’évolution de l’état du chien. Une liste de médicaments utilisés dans la prise en charge de l’IRC figure dans le Tableau 5. […]
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
How to reference this publication (Harvard system)?
Affiliation of the authors at the time of publication
1Royal Canin USA, MO, USA. 2Experimental Physiopathology and Toxicology, National Veterinary School of Toulouse, Toulouse, France.
Comments (0)
Ask the author
0 comments